You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The partners will assess Stella's assay by quantifying proto-oncogenes in Barrett's esophagus tissue that have progressed to cancer, and those that have not.
Oxford Immunotec's T-Spot Discovery SARC-CoV-2 test will be used to assess whether Valneva's vaccine candidate induces a T-cell response.
The study aims to evaluate how pairing Sera's PreTRM test with clinical interventions may mitigate preterm birth risk, improve neonatal outcomes, and reduce healthcare costs.
The study, called TRAMmoniTTR, will longitudinally monitor the clinical status of both symptomatic and asymptomatic participants with variants in the TTR gene.
Ginkgo will offer Access Bio's antigen tests through its Concentric by Ginkgo service.
The companies aim to identify biomarkers that can be used to diagnose early-onset Parkinson's disease, as well as track disease progression.
Called CoronaDx, which has a budget of €3 million, aims to facilitate the development of testing systems for use in remote areas with limited infrastructure.
Quidel's preliminary earnings more than doubled over the prior quarter on increasing SARS-CoV-2 test sales.
Unilabs Denmark, the local subsidiary of the European diagnostic services provider, will carry out antibody testing as part of the effort.
Data generated via the platform will be used to inform UK National Health Service policy.